. Based on this, scRNA-seq can help identify specific molecular markers and therapeutic targets of PTC. ARHGAP36, a RhoGTPase activating protein, has been identified from a genome-scale cDNA overexpression screen ( Rack et al. 2014 ). Bulk normal
. Based on this, scRNA-seq can help identify specific molecular markers and therapeutic targets of PTC. ARHGAP36, a RhoGTPase activating protein, has been identified from a genome-scale cDNA overexpression screen ( Rack et al. 2014 ). Bulk normal